Bunkerhill ECG-EF vs iCAC Device
AI Verdict
Choose Bunkerhill ECG-EF if…
Choose Bunkerhill ECG-EF if you need a rapid, non-invasive screening tool to identify patients at risk for heart failure by detecting reduced left ventricular ejection fraction from routine 12-lead ECGs. This is ideal for primary care, emergency departments, or cardiology clinics looking to integrate an automated, accessible solution for early heart failure risk stratification into existing clinical workflows.
View Bunkerhill ECG-EF →Choose iCAC Device if…
Choose Bunkerhill Health's iCAC Device if you aim to opportunistically detect and quantify coronary artery calcium from routine, non-contrast chest CT scans to aid in early cardiovascular disease detection. This tool is best suited for radiology departments or healthcare systems seeking to leverage existing imaging data to identify patients at risk for coronary artery disease, providing adjunctive information to radiologists.
View iCAC Device →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Bunkerhill ECG-EF | iCAC Device |
|---|---|---|
| Pricing | Contact sales for pricing details. | Contact for pricing |
| Deployment | Cloud-native platform (Carebricks) that integrates with existing health system infrastructure like EHRs. | Software as a Medical Device (SaMD), integrates with PACS or DICOM router. Cloud-based (via Carebricks platform). |
| FDA Status | Yes AI-estimated | 1 AI-estimated |
| HIPAA | Yes AI-estimated | Unknown |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Bunkerhill ECG-EFTool A (Bunkerhill ECG-EF) analyzes routine 12-lead ECG data, which is a widely available, non-invasive, and rapid diagnostic input. While Tool B (iCAC Device) also integrates seamlessly with existing systems, its reliance on CT scans, though routine, is generally less accessible and involves radiation compared to an ECG, giving Tool A a slight edge in broad usability for initial screening.
Clinical Value
iCAC DeviceBoth tools offer significant clinical value for early detection of cardiac conditions. However, Tool B (iCAC Device) not only detects coronary artery calcium but also quantifies it in Agatston units and provides visual segmentation, offering a more detailed and objective assessment for risk stratification. This quantitative output provides a higher degree of actionable clinical information.
Pricing & Value
TieBoth Tool A and Tool B explicitly state 'contact for pricing' in their specifications, and no public pricing information was found through web searches. Without any transparent pricing details, it is impossible to compare their value propositions or determine a winner in this dimension.
Enterprise Readiness
Bunkerhill ECG-EFTool A (Bunkerhill ECG-EF) explicitly states 'has_baa': 'yes' and 'hipaa_compliant': 'yes', providing clear transparency on crucial enterprise compliance aspects. In contrast, Tool B (iCAC Device) requires contacting the vendor for details on BAA and HIPAA compliance, indicating less upfront readiness transparency. Both are FDA-cleared and integrate with the Carebricks platform.
Innovation
Bunkerhill ECG-EFBoth tools represent significant innovation in applying AI to cardiology diagnostics. However, Tool A's ability to detect reduced Left Ventricular Ejection Fraction (LVEF) from a routine 12-lead ECG is particularly innovative, as LVEF typically requires more specialized imaging like echocardiography. This makes a complex diagnostic parameter accessible through a common, low-cost test, potentially broadening early detection significantly.
Support & Docs
TieNeither the provided structured facts nor the web search results offer specific differentiating information regarding support tiers, service level agreements, or comprehensive public documentation for either Tool A or Tool B. As both products are from the same company (Bunkerhill Health) and part of the Carebricks platform, it is reasonable to assume they share a common support infrastructure.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Bunkerhill ECG-EF | iCAC Device |
|---|---|---|
| Name | Bunkerhill ECG-EF | iCAC Device |
| Primary Clinical Purpose | Detects reduced left ventricular ejection fraction (LVEF u2264 40%), aiding in the early identification of patients at risk for heart failure. | Detects and quantifies coronary artery calcium from routine, non-contrast, non-gated chest CT scans, aiding in early cardiovascular disease detection. |
| Input Data Type | Routine 12-lead electrocardiograms (ECGs) | Routine, non-contrast, non-gated chest CT scans |
| Company | BunkerHill Health | Bunkerhill Health |
| Specific Output/Analysis | AI algorithm to detect reduced Left Ventricular Ejection Fraction (LVEF u2264 40%) | Estimates presence and quantity of coronary artery calcium (CAC); Outputs visual representation of estimated CAC segmentation; Delivers exact and four-category quantitative estimates of CAC burden in Agatston units. |
| Categories | Cardiology AI | Cardiology AI |
Videos
Demos, reviews, and walkthroughs featuring Bunkerhill ECG-EF and iCAC Device.